Dr. Fiellin has focused his scholarly work on the interface between primary care and substance abuse. He conducts research on the transfer of treatment strategies, including opioid agonist treatment with buprenorphine and alcohol pharmacotherapies, from specialized settings to office-based, primary care, emergency department and HIV specialty settings.
Specialized Terms: Substance abuse treatment in primary care; Emergency department and HIV specialty settings opioid agonist treatment with buprenorphine; Pharmacologic treatment of alcohol
Alcoholism; Buprenorphine; Health Policy; HIV; Internal Medicine; Opioid-Related Disorders; Public Health; Substance Withdrawal Syndrome; Tobacco Use Disorder; Substance Abuse Detection; Substance Abuse Treatment Centers; Clinical Trial; Multicenter Study; Meta-Analysis; Health Care Quality, Access, and Evaluation; Cocaine-Related Disorders; Alcohol-Related Disorders; Drug Overdose; Observational Study; Addiction Medicine; Marijuana Use; Implementation Science; Systematic Review
| Conditions | Study Title |
|---|---|
| Addictive Behaviors | Clinical Determinants of Unintended Prolonged Opioid Use |
| Addictive Behaviors; Mental Health & Behavioral Research | Support Models for Addiction Related Treatment (SMART) Trial of Opioid Use Disorder in Pregnant Women |
| Addictive Behaviors; Alcohol Addiction; Mental Health & Behavioral Research | Prazosin for Alcohol Use Disorder |
| HIV/AIDS; Infectious Diseases; Tobacco Addiction | A Smart Approach to Treating Tobacco Use Disorder in Persons Living With HIV (SMARTTT) |